GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT04456998 · COMPLETED
Trial details
- NCT number
- NCT04456998
- Sponsor
- GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-12
- Primary completion
- 2022-10-17
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.